Skip to content

Reported March 13, 2025 · Before market open

Revenue$54.4MBeat by $3.4M
EPS-$0.12In line
Revenue estimate$51.0M
EPS estimate-$0.12

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$67.2M
EPS estimate-$0.04

Financials

Q4 2024

Income statement

See full
Revenue$36.4M-23.4%
Gross profit$5.0M-44.4%
Operating income-$5.9M+83.4%
Net income-$9.8M+71.1%
EPS (diluted)-$0.12+73.9%

Balance sheet

See full
Cash & equivalents$19.6M-32.3%
Total debt$9.3M-62.0%
Total equity$221.9M-5.3%
Total assets$256.7M-13.0%

Cash flow

See full
Operating cash flow-$1.8M+81.2%
CapEx$4.6M+18,967%
Free cash flow-$6.3M+32.3%

Valuation & ratios

Profitability

See full
Gross margin20.3%+1.6pp
Operating margin-18.2%-5.2pp
Net margin-14.2%-4.3pp
FCF margin-17.4%+1.8pp

Returns & leverage

See full
Return on equity-12%-3.8pp
Debt / equity-0.1×
Current ratio7.1×+1.3×

Segments

By segment

See full
Logistics$36.7M
Clinical-

By product

See full
Other Clinical-
Transplant Clinical-

Versus estimates

Ask the moment Strata Critical Medical, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Strata Critical Medical, Inc. report Q4 2024 earnings?
Strata Critical Medical, Inc. (SRTA) reported Q4 2024 earnings on March 13, 2025 before market open.
What were Strata Critical Medical, Inc.'s Q4 2024 revenue and EPS?
Strata Critical Medical, Inc. reported revenue of $54.4M and eps of $-0.12 for Q4 2024.
Did Strata Critical Medical, Inc. beat estimates in Q4 2024?
Revenue beat the consensus estimate of $51.0M by $3.4M. EPS beat the consensus estimate of $-0.12 by $0.00.
Where can I find Strata Critical Medical, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001779128-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.